prevention of sudden death

Description Results NMA

azimilide 100 mg (n=-9)

vs.

placebo (n=-9)

double blind

Parallel groups

Sample size: -9/-9

Primary endpoint:

FU duration: 1y

dofetilide (n=-9)

vs.

placebo (n=-9)

double blind

Parallel groups

Sample size: -9/-9

Primary endpoint:

FU duration: >12 months

moricizine for 14 days (n=665)

vs.

placebo (n=660)

double blind

Parallel groups

Sample size: 665/660

Primary endpoint: mortality

FU duration: 14 days

long term moricizine (n=1155)

vs.

placebo (n=0)

double blind

Parallel groups

Sample size: 1155/0

Primary endpoint: mortality

FU duration: